Dividend History

Forecast Next Dividend Date: Wednesday 20 March 2019
Days remaining until next forecast dividend: 29
This is only a forecast. Forecast ex-dividend dates are taken from company's website or by using previous ex-dividend dates as a guide. Please confirm ex-dividend date with your broker.

Dividend Star Rating for PROBIOTEC(PBP)



Dividend Growth

Relative Strength

Earnings Growth


Fundamental Data for PROBIOTEC(PBP)

Sector: Pharmaceuticals Biotechnology & Li
Price: $1.51 (delayed)
Year High: $1.80
Year Low: $0.47
Market Capitalisation: $0.104 billion
Net Tangible Assets: $0 billion
Earnings per Share: 0 cents
Price Earnings Ratio: 29
Forecast Earnings Growth (5 years): 0% per annum
Dividend Cover: 2.08

Dividend Payment History for PROBIOTEC(PBP)

Ex-Dividend Date Books Close Date Date Payable Amount Franking Franking Credit Gross Dividend Cum Div Price Gross Yield RoI


  • Care should be taken interpreting this chart as all dividend payments for final year may not have been paid.
  • The financial year that the dividend is allocated depends on the payment date of the dividend, not the ex-dividend date.
  • Dividend history has not been adjusted for any capital reconstructions which may have effected dividend entitlement per share.

Dividend News Articles for PROBIOTEC(PBP)

Probiotec sells brand assets to iNova Pharmaceuticals - Small Caps
Probiotec sells brand assets to iNova Pharmaceuticals  Small Caps

Pharmaceutical company Probiotec (ASX: PBP) has agreed to sell the Gold Cross, David Craig and Skin Basics brands, including all intellectual property and ...

Blackmores Share Price Rises on New Acquisition and Record Sales - Money Morning Australia
Blackmores Share Price Rises on New Acquisition and Record Sales  Money Morning Australia

Blackmores Limited [ASX:BKL] share price increased immediately upon opening, after revealing the acquisition of Probiotec Limited's [ASX:PBP] IMPROMY ...

Why wellness stock Probiotec is a picture of health - Stockhead
Why wellness stock Probiotec is a picture of health  Stockhead

Looking for a healthier, more diverse ASX portfolio? Our resident expert Tim Boreham explains why you need to be investing in probiotic health stocks.

VICOM Ltd (SGX:V01): Did It Outperform The Industry? - Simply Wall St
VICOM Ltd (SGX:V01): Did It Outperform The Industry?  Simply Wall St

After reading VICOM Ltd's (SGX:V01) latest earnings update (30 June 2018), I found it beneficial to look back at how the company has performed in the past and ...

Should Investors Hold Tight To Probiotec Limited (ASX:PBP) In Their Porfolio With Sales Growth of 0.19455? - Troy Business News
Should Investors Hold Tight To Probiotec Limited (ASX:PBP) In Their Porfolio With Sales Growth of 0.19455?  Troy Business News

Potential Investors often look for key drivers that can move a stock in a positive direction. One of those is sales growth. Probiotec Limited (ASX:PBP) of the ...

The information provided on this website is for use of a general nature only and is not intended to be relied upon as, nor to be a substitute for, specific professional or investment advice. The team at Dividends.com.au are not lawyers, financial planners, investment advisers, or accountants. So, before taking any action or risking any money, you should always check with your own qualified professional advisers.